Btk inhibitors (Genentech/Gilead)

N/A

Report date: 2025/06/11 20:01:15
NME

Base Information

Drug NameBtk inhibitors (Genentech/Gilead)
Drug Alias NameBtk inhibitors (CGI/ Genentech)Btk inhibitors (Gilead/ Genentech)G-309GDC-744G-020 +[8] 
ClassificationSmall molecules
Mechanisms of ActionAnticancer protein kinase inhibitorsImmunomodulatorsTyrosine-protein kinase BTK inhibitors
TargetsTyrosine-protein kinase BTK
Therapy Area/IndicationsAutoimmune DiseasesLymphoma, B-Cell
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesCGI Pharmaceuticals Inc
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesGilead Sciences IncGenentech IncCGI Pharmaceuticals Inc
Active IndicationsN/A
Inactive IndicationsAutoimmune DiseasesLymphoma, B-Cell

Other Information

ATC CodeN/A
Related LinksN/A